These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31506486)

  • 1. Novel Method for Rapid Assessment of Cognitive Impairment Using High-Performance Eye-Tracking Technology.
    Oyama A; Takeda S; Ito Y; Nakajima T; Takami Y; Takeya Y; Yamamoto K; Sugimoto K; Shimizu H; Shimamura M; Katayama T; Rakugi H; Morishita R
    Sci Rep; 2019 Sep; 9(1):12932. PubMed ID: 31506486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early detection of cognitive decline in mild cognitive impairment and Alzheimer's disease with a novel eye tracking test.
    Tadokoro K; Yamashita T; Fukui Y; Nomura E; Ohta Y; Ueno S; Nishina S; Tsunoda K; Wakutani Y; Takao Y; Miyoshi T; Higashi Y; Osakada Y; Sasaki R; Matsumoto N; Kawahara Y; Omote Y; Takemoto M; Hishikawa N; Morihara R; Abe K
    J Neurol Sci; 2021 Aug; 427():117529. PubMed ID: 34130064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.
    Pinto TCC; Machado L; Costa MLG; Santos MSP; Bulgacov TM; Rolim APP; Silva GA; Rodrigues-Júnior AL; Sougey EB; Ximenes RCC
    Dement Geriatr Cogn Disord; 2019; 47(4-6):366-374. PubMed ID: 31466064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Device-Embedded Cameras for Eye Tracking-Based Cognitive Assessment: Validation With Paper-Pencil and Computerized Cognitive Composites.
    Bott N; Madero EN; Glenn J; Lange A; Anderson J; Newton D; Brennan A; Buffalo EA; Rentz D; Zola S
    J Med Internet Res; 2018 Jul; 20(7):e11143. PubMed ID: 30042093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The AD8 (Dementia Screening Interview) is a valid and reliable screening scale not only for dementia but also for mild cognitive impairment in the Turkish geriatric outpatients.
    Usarel C; Dokuzlar O; Aydin AE; Soysal P; Isik AT
    Int Psychogeriatr; 2019 Feb; 31(2):223-229. PubMed ID: 29923472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility of the Addenbrooke's Cognitive Examination - III (ACE-III), Mini-ACE, Mini-Mental State Examination, Montreal Cognitive Assessment, and Hasegawa Dementia Scale-Revised for detecting mild cognitive impairment and dementia.
    Senda M; Terada S; Takenoshita S; Hayashi S; Yabe M; Imai N; Horiuchi M; Yamada N
    Psychogeriatrics; 2020 Mar; 20(2):156-162. PubMed ID: 31448862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis.
    Ciesielska N; Sokołowski R; Mazur E; Podhorecka M; Polak-Szabela A; Kędziora-Kornatowska K
    Psychiatr Pol; 2016 Oct; 50(5):1039-1052. PubMed ID: 27992895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study on the validations of three cognitive screening tests in identifying subtle cognitive decline.
    Pan FF; Huang L; Chen KL; Zhao QH; Guo QH
    BMC Neurol; 2020 Mar; 20(1):78. PubMed ID: 32138678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing a Brief Neuropsychological Battery for Early Diagnosis of Cognitive Impairment.
    Liew TM
    J Am Med Dir Assoc; 2019 Aug; 20(8):1054.e11-1054.e20. PubMed ID: 30992186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of a Brief Neuropsychological Battery for the Diagnosis of Dementia and Mild Cognitive Impairment: An Analysis of the NEDICES Cohort.
    Serna A; Contador I; Bermejo-Pareja F; Mitchell AJ; Fernández-Calvo B; Ramos F; Villarejo A; Benito-León J
    J Alzheimers Dis; 2015; 48(1):163-73. PubMed ID: 26401937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The repeatable battery for the assessment of the neuropsychological status (RBANS): a diagnostic validity study in Greek elderly.
    Tsatali M; Fotiadou F; Giaglis G; Tsolaki M
    Aging Clin Exp Res; 2019 Sep; 31(9):1305-1312. PubMed ID: 30471005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Can We Best Screen for Cognitive Impairment in Malaysia? A Pilot of the IDEA Cognitive Screen and Picture-Based Memory Impairment Scale and Comparison of Criterion Validity with the Mini Mental State Examination.
    Rosli R; Tan MP; Gray WK; Subramanian P; Mohd Hairi NN; Chin AV
    Clin Gerontol; 2017; 40(4):249-257. PubMed ID: 28459304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Abbreviated Montreal Cognitive Assessment (MoCA) for Dementia Screening.
    Horton DK; Hynan LS; Lacritz LH; Rossetti HC; Weiner MF; Cullum CM
    Clin Neuropsychol; 2015; 29(4):413-25. PubMed ID: 25978540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clock Drawing Test: A Simple Scoring System for the Accurate Screening of Cognitive Impairment in Patients with Mild Cognitive Impairment and Dementia.
    Rakusa M; Jensterle J; Mlakar J
    Dement Geriatr Cogn Disord; 2018; 45(5-6):326-334. PubMed ID: 30036864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new device-aided cognitive function test, User eXperience-Trail Making Test (UX-TMT), sensitively detects neuropsychological performance in patients with dementia and Parkinson's disease.
    Kokubo N; Yokoi Y; Saitoh Y; Murata M; Maruo K; Takebayashi Y; Shinmei I; Yoshimoto S; Horikoshi M
    BMC Psychiatry; 2018 Jul; 18(1):220. PubMed ID: 29976167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of Montreal Cognitive Assessment in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders: major and mild neurocognitive disorders.
    Liew TM; Feng L; Gao Q; Ng TP; Yap P
    J Am Med Dir Assoc; 2015 Feb; 16(2):144-8. PubMed ID: 25282632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of saccadic eye movements in dementia due to Alzheimer's disease and mild cognitive impairment.
    Wilcockson TDW; Mardanbegi D; Xia B; Taylor S; Sawyer P; Gellersen HW; Leroi I; Killick R; Crawford TJ
    Aging (Albany NY); 2019 Aug; 11(15):5389-5398. PubMed ID: 31375642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal cutoff scores for dementia and mild cognitive impairment of the Montreal Cognitive Assessment among elderly and oldest-old Chinese population.
    Tan JP; Li N; Gao J; Wang LN; Zhao YM; Yu BC; Du W; Zhang WJ; Cui LQ; Wang QS; Li JJ; Yang JS; Yu JM; Xia XN; Zhou PY
    J Alzheimers Dis; 2015; 43(4):1403-12. PubMed ID: 25147113
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.